Evidence map›Paper›PMID 31877712›Full record

ReviewInternational journal of molecular sciences2019

Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy.

Spencer G Miller, Paul S Hafen, Jeffrey J Brault

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Advances in metabolomics of chronic obstructive pulmonary disease.Chinese medical journal pulmonary and critical care medicine · 2023
    Review
  15. Energy Regulation in Inflammatory Sarcopenia by the Purinergic System.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Spencer G MillerIndiana Center for Musculoskeletal Health, Indiana University School of Medicine, Department of Anatomy, Cell Biology & Physiology, 635 Barnhill Dr., Van Nuys Medical Science Bldg. 5035, Indianapolis, IN 46202, USA.
Paul S HafenIndiana Center for Musculoskeletal Health, Indiana University School of Medicine, Department of Anatomy, Cell Biology & Physiology, 635 Barnhill Dr., Van Nuys Medical Science Bldg. 5035, Indianapolis, IN 46202, USA.
Jeffrey J BraultIndiana Center for Musculoskeletal Health, Indiana University School of Medicine, Department of Anatomy, Cell Biology & Physiology, 635 Barnhill Dr., Van Nuys Medical Science Bldg. 5035, Indianapolis, IN 46202, USA.ORCID 0000-0003-3503-0528
Indiana University School of Medicine

Funding

CELLULAR ENERGETICS AS A REGULATOR OF MUSCLE MASS AND MITOCHONDRIAL CONTENT DURING MUSCLE ATROPHYR01AR070200 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI BRAULT, JEFFREY J · 2017 to 2021
$1.6M
NIAMS NIH HHS R01 AR070200
6 · The paper itself

Abstract

Adenine nucleotides (AdNs: ATP, ADP, AMP) are essential biological compounds that facilitate many necessary cellular processes by providing chemical energy, mediating intracellular signaling, and regulating protein metabolism and solubilization. A dramatic reduction in total AdNs is observed in atrophic skeletal muscle across numerous disease states and conditions, such as cancer, diabetes, chronic kidney disease, heart failure, COPD, sepsis, muscular dystrophy, denervation, disuse, and sarcopenia. The reduced AdNs in atrophic skeletal muscle are accompanied by increased expression/activities of AdN degrading enzymes and the accumulation of degradation products (IMP, hypoxanthine, xanthine, uric acid), suggesting that the lower AdN content is largely the result of increased nucleotide degradation. Furthermore, this characteristic decrease of AdNs suggests that increased nucleotide degradation contributes to the general pathophysiology of skeletal muscle atrophy. In view of the numerous energetic, and non-energetic, roles of AdNs in skeletal muscle, investigations into the physiological consequences of AdN degradation may provide valuable insight into the mechanisms of muscle atrophy.

Indexed as

Adenine NucleotidesAnimalsHumansMuscle, SkeletalMuscular Disorders, AtrophicSarcopeniaXanthinesAdenine NucleotidesXanthinesadenine nucleotideAMPATPatrophycachexiaenergeticsmusclesarcopeniauric acid

Identifiers

PMID31877712
PMCPMC6981514
OpenAlexW2994957013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.